115 related articles for article (PubMed ID: 22277403)
1. [A drug targeting intracellular amyloid-β and oxidative stress: apomorphine].
Ohyagi Y
Rinsho Shinkeigaku; 2011 Nov; 51(11):884-7. PubMed ID: 22277403
[TBL] [Abstract][Full Text] [Related]
2. Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation.
Himeno E; Ohyagi Y; Ma L; Nakamura N; Miyoshi K; Sakae N; Motomura K; Soejima N; Yamasaki R; Hashimoto T; Tabira T; LaFerla FM; Kira J
Ann Neurol; 2011 Feb; 69(2):248-56. PubMed ID: 21387370
[TBL] [Abstract][Full Text] [Related]
3. Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer's Disease.
Nakamura N; Ohyagi Y; Imamura T; Yanagihara YT; Iinuma KM; Soejima N; Murai H; Yamasaki R; Kira JI
J Alzheimers Dis; 2017; 58(4):1151-1161. PubMed ID: 28550243
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Strategies for Alzheimer's Disease in the View of Diabetes Mellitus.
Ohyagi Y; Miyoshi K; Nakamura N
Adv Exp Med Biol; 2019; 1128():227-248. PubMed ID: 31062332
[TBL] [Abstract][Full Text] [Related]
5. Apomorphine and Alzheimer Aβ: roles for regulated α cleavage, autophagy, and antioxidation?
Steele JW; Gandy S
Ann Neurol; 2011 Feb; 69(2):221-5. PubMed ID: 21387363
[No Abstract] [Full Text] [Related]
6. Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.
Soejima N; Ohyagi Y; Nakamura N; Himeno E; Iinuma KM; Sakae N; Yamasaki R; Tabira T; Murakami K; Irie K; Kinoshita N; LaFerla FM; Kiyohara Y; Iwaki T; Kira J
Curr Alzheimer Res; 2013 Jan; 10(1):11-20. PubMed ID: 22950910
[TBL] [Abstract][Full Text] [Related]
7. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
8. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
9. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
[TBL] [Abstract][Full Text] [Related]
10. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
11. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
12. A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta.
Hilt S; Altman R; Kálai T; Maezawa I; Gong Q; Wachsmann-Hogiu S; Jin LW; Voss JC
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103547
[TBL] [Abstract][Full Text] [Related]
13. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
14. Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease.
Zhou WW; Lu S; Su YJ; Xue D; Yu XL; Wang SW; Zhang H; Xu PX; Xie XX; Liu RT
Free Radic Biol Med; 2014 Sep; 74():50-63. PubMed ID: 24960578
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
16. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
Higuchi M; Iwata N; Saido TC
Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
[TBL] [Abstract][Full Text] [Related]
17. Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease.
Ohyagi Y
Curr Alzheimer Res; 2008 Dec; 5(6):555-61. PubMed ID: 19075582
[TBL] [Abstract][Full Text] [Related]
18. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
Xu PX; Wang SW; Yu XL; Su YJ; Wang T; Zhou WW; Zhang H; Wang YJ; Liu RT
Behav Brain Res; 2014 May; 264():173-80. PubMed ID: 24512768
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
